The amyloid proteome: a systematic review and proposal of a protein classification system

References

• Adachi M, Kitamura M, Muta K, Maekawa A, Uramatsu T, Tadokoro M, Funakoshi S, Hisano S, Kuwahara N, Shimizu A, et al. 2020. IgM monoclonal gammopathy with heavy-and-light-chain amyloidosis resembling fibrillary glomerulonephritis determined by tandem mass spectrometry: a case report. BMC Nephrol. 21:195.
   PubMed Web of Science ®Google Scholar
• Alexander MP, Dasari S, Vrana JA, Riopel J, Valeri AM, Markowitz GS, Hever A, Bijol V, Larsen CP, Cornell LD, et al. 2018. Congophilic fibrillary glomerulonephritis: a case series. Am J Kidney Dis. 72:325–336. eng.
   PubMed Web of Science ®Google Scholar
• Ancsin JB, Kisilevsky R. 1999. The heparin/heparan sulfate-binding site on apo-serum amyloid A. J Biol Chem. 274:7172–7181.
   PubMed Web of Science ®Google Scholar
• Baranova IN, Bocharov AV, Vishnyakova TG, Kurlander R, Chen Z, Fu D, Arias IM, Csako G, Patterson AP, Eggerman TL. 2010. CD36 is a novel Serum Amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cells. J Biol Chem. 285:8492–8506. eng.
   PubMedGoogle Scholar
• Baumgart J-V, Stuhlmann-Laeisz C, Hegenbart U, Nattenmüller J, Schönland S, Krüger S, Behrens H-M, Röcken C. 2018. Local vs. systemic pulmonary amyloidosis-impact on diagnostics and clinical management. Virchows Arch. 473:627–637. eng.
   PubMed Web of Science ®Google Scholar
• Benson MD, Buxbaum JN, Eisenberg DS, Merlini G, Saraiva MJM, Sekijima Y, Sipe JD, Westermark P. 2020. Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid. 27:217–222.
   PubMed Web of Science ®Google Scholar
• Bogie JFJ, Dierckx T, Erens C, Grajchen E, Haidar M, Hardonnière K, Hendriks JJA, Hendrix S, Kerdine-Römer S, Broeckhoven JV, et al. 2020. CD36-mediated uptake of myelin debris by macrophages and microglia reduces neuroinflammation. J Neuroinflammation. 17:224. eng.
   PubMed Web of Science ®Google Scholar
• Brambilla F, Lavatelli F, Di Silvestre D, Valentini V, Palladini G, Merlini G, Mauri P. 2013. Shotgun protein profile of human adipose tissue and its changes in relation to systemic amyloidoses. J Proteome Res. 12:5642–5655.
   PubMed Web of Science ®Google Scholar
• Brambilla F, Lavatelli F, Di Silvestre D, Valentini V, Rossi R, Palladini G, Obici L, Verga L, Mauri P, Merlini G. 2012. Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue. Blood. 119:1844–1847.
   PubMed Web of Science ®Google Scholar
• Bristow CL, Boackle RJ. 1986. Evidence for the binding of human serum amyloid P component to C1q and Fabγ. Mol Immunol. 23(10):1045–1052.
   PubMed Web of Science ®Google Scholar
• Butler PJG, Tennent GA, Pepys MB. 1990. Pentraxin-chromatin interactions: serum amyloid P component specifically displaces H1-type histones and solubilizes native long chromatin. J Exp Med. 172:13–18. eng.
   PubMed Web of Science ®Google Scholar
• Chiti F, Dobson CM. 2017. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu Rev Biochem. 86:27–68.
   PubMed Web of Science ®Google Scholar
• Cohen AD, Comenzo RL. 2010. Systemic light-chain amyloidosis: advances in diagnosis, prognosis, and therapy. Hematology Am Soc Hematol Educ Program. 2010:287–294. eng.
   PubMed Web of Science ®Google Scholar
• Coker AR, Purvis A, Baker D, Pepys MB, Wood SP. 2000. Molecular chaperone properties of serum amyloid P component. FEBS Lett. 473(2):199–202.
   PubMed Web of Science ®Google Scholar
• Comenzo RL. 2014. LECT2 makes the amyloid list. Blood. 123:1436–1437.
   PubMed Web of Science ®Google Scholar
• Dallacasagrande V, Hajjar KA. 2020. Annexin A2 in inflammation and host defense. Cells. 9(6):1499.
   PubMed Web of Science ®Google Scholar
• Damy T, Plante-Bordeneuve V, Dogan A. 2014. Characterization of untyped cardiac amyloidosis by mass spectrometry in a patient with Gly6Ser transthyretin polymorphism in fatal cardiogenic shock. Arch Cardiovasc Dis. 107:706–708.
   PubMed Web of Science ®Google Scholar
• Dasari S, Alexander MP, Vrana JA, Theis JD, Mills JR, Negron V, Sethi S, Dispenzieri A, Highsmith WE, Jr., Nasr SH, et al. 2018. DnaJ heat shock protein family B member 9 is a novel biomarker for fibrillary GN. J Am Soc Nephrol. 29:51–56.
   PubMed Web of Science ®Google Scholar
• Dasari S, Amin MS, Kurtin PJ, Vrana JA, Theis JD, Grogg KL, Alexander MP, Nasr SH, Fervenza FC, Leung N, et al. 2016. Clinical, biopsy, and mass spectrometry characteristics of renal apolipoprotein A-IV amyloidosis. Kidney Int. 90:658–664.
   PubMed Web of Science ®Google Scholar
• Dasari S, Theis JD, Vrana JA, Rech KL, Dao LN, Howard MT, Dispenzieri A, Gertz MA, Hasadsri L, Highsmith WE, et al. 2020. Amyloid typing by mass spectrometry in clinical practice: a comprehensive review of 16,175 samples. Mayo Clin Proc. 95(9):1852–1864.
   PubMed Web of Science ®Google Scholar
• Dobri A-M, Dudău M, Enciu A-M, Hinescu ME. 2021. CD36 in alzheimer's disease: an overview of molecular mechanisms and therapeutic targeting. Neuroscience. 453:301–311.
   PubMed Web of Science ®Google Scholar
• Dogan A. 2017. Amyloidosis: insights from proteomics. Annu Rev Pathol Mech Dis. 12:277–304.
   PubMed Web of Science ®Google Scholar
• Doll S, Dreßen M, Geyer PE, Itzhak DN, Braun C, Doppler SA, Meier F, Deutsch M-A, Lahm H, Lange R, et al. 2017. Region and cell-type resolved quantitative proteomic map of the human heart. Nat Commun. 8:1469.
   PubMed Web of Science ®Google Scholar
• D’Souza A, Theis J, Quint P, Kyle R, Gertz M, Zeldenrust S, Vrana J, Dogan A, Dispenzieri A. 2013. Exploring the amyloid proteome in immunoglobulin-derived lymph node amyloidosis using laser microdissection/tandem mass spectrometry. Am J Hematol. 88:577–580.
   PubMed Web of Science ®Google Scholar
• D’Souza A, Theis JD, Vrana JA, Dogan A. 2014. Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration. Amyloid. 21:71–75.
   PubMed Web of Science ®Google Scholar
• Efebera YA, Sturm A, Baack EC, Hofmeister CC, Satoskar A, Nadasdy T, Nadasdy G, Benson DM, Gillmore JD, Hawkins PN, et al. 2014. Novel gelsolin variant as the cause of nephrotic syndrome and renal amyloidosis in a large kindred. Amyloid. 21:110–112.
   PubMed Web of Science ®Google Scholar
• Emsley J, White HE, O'Hara BP, Oliva G, Srinivasan N, Tickle IJ, Blundell TL, Pepys MB, Wood SP. 1994. Structure of pentameric human serum amyloid P component. Nature. 367:338–345.
   PubMed Web of Science ®Google Scholar
• Freudenthaler S, Hegenbart U, Schönland S, Behrens H-M, Krüger S, Röcken C. 2016. Amyloid in biopsies of the gastrointestinal tract-a retrospective observational study on 542 patients. Virchows Arch. 468(5):569–577.
   PubMed Web of Science ®Google Scholar
• Gabelica V, Shvartsburg AA, Afonso C, Barran P, Benesch JLP, Bleiholder C, Bowers MT, Bilbao A, Bush MF, Campbell JL, et al. 2019. Recommendations for reporting ion mobility Mass Spectrometry measurements. Mass Spectrom Rev. 38:291–320.
   PubMed Web of Science ®Google Scholar
• Garnier S. 2018. viridis: Default Color Maps from 'matplotlib'. [place unknown]: [publisher unknown]. R package version 0.5.1; [accessed 2020 Oct 4]. https://cran.r-project.org/package=viridis.
   Google Scholar
• Glatz JFC, Luiken JJFP. 2018. Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization. J Lipid Res. 59:1084–1093.
   PubMed Web of Science ®Google Scholar
• Greene MJ, Sam F, Soo Hoo PT, Patel RS, Seldin DC, Connors LH. 2011. Evidence for a functional role of the molecular chaperone clusterin in amyloidotic cardiomyopathy. Am J Pathol. 178:61–68.
   PubMed Web of Science ®Google Scholar
• Gu Z, Eils R, Schlesner M. 2016. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 32:2847–2849.
   PubMed Web of Science ®Google Scholar
• Gu Z, Gu L, Eils R, Schlesner M, Brors B. 2014. circlize implements and enhances circular visualization in R. Bioinformatics. 30:2811–2812.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Reis ES, Mastellos DC, Ricklin D, Lambris JD. 2017. Novel mechanisms and functions of complement. Nat Immunol. 18:1288–1298.
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Serrano-Pozo A, Hori Y, Adams KW, Takeda S, Banerji AO, Mitani A, Joyner D, Thyssen DH, Bacskai BJ, et al. 2012. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide. J Neurosci. 32(43):15181–15192.
   PubMed Web of Science ®Google Scholar
• Helder MRK, Schaff HV, Nishimura RA, Gersh BJ, Dearani JA, Ommen SR, Mereuta OM, Theis JD, Dogan A, Edwards WD. 2014. Impact of incidental amyloidosis on the prognosis of patients with hypertrophic cardiomyopathy undergoing septal myectomy for left ventricular outflow tract obstruction. Am J Cardiol. 114(9):1396–1399.
   PubMed Web of Science ®Google Scholar
• Horike K, Takeda A, Tsujita M, Goto N, Watarai Y, Uchida K, Katayama A, Nishihira M, Shimizu A, Nozu K, et al. 2018. Two novel APOA1 gene mutations in a Japanese renal transplant recipient with recurrent apolipoprotein A-I related amyloidosis. Nephrology. 23 (Suppl 2):17–21.
   PubMedGoogle Scholar
• Ikegawa M, Nirasawa T, Kakuda N, Miyasaka T, Kuzuhara Y, Murayama S, Ihara Y. 2019. Visualization of Amyloid β deposits in the human brain with matrix-assisted laser desorption/ionization imaging mass spectrometry. J Vis Exp.
   PubMed Web of Science ®Google Scholar
• Jasra SK, Badian C, Macri I, Ra P. 2012. Recognition of early myocardial infarction by immunohistochemical staining with cardiac troponin-I and complement C9. J Forensic Sci. 57(6):1595–1600.
   PubMed Web of Science ®Google Scholar
• Jenkins CP, Cardona DM, Bowers JN, Oliai BR, Allan RW, Normann SJ. 2010. The utility of C4d, C9, and troponin T immunohistochemistry in acute myocardial infarction. Arch Pathol Lab Med. 134:256–263.
   PubMed Web of Science ®Google Scholar
• Ke PC, Zhou R, Serpell LC, Riek R, Knowles TPJ, Lashuel HA, Gazit E, Hamley IW, Davis TP, Fändrich M, et al. 2020. Half a century of amyloids: past, present and future. Chem Soc Rev. 49:5473–5509.
   PubMed Web of Science ®Google Scholar
• Kedia N, Arhzaouy K, Pittman SK, Sun Y, Batchelor M, Weihl CC, Bieschke J. 2019. Desmin forms toxic, seeding-competent amyloid aggregates that persist in muscle fibers. Proc Natl Acad Sci USA. 116:16835–16840.
   PubMed Web of Science ®Google Scholar
• Khan T, Muise ES, Iyengar P, Wang ZV, Chandalia M, Abate N, Zhang BB, Bonaldo P, Chua S, Scherer PE. 2009. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol. 29:1575–1591.
   PubMed Web of Science ®Google Scholar
• Kisilevsky R. 2000. The relation of proteoglycans, serum amyloid P and apo E to amyloidosis current status, 2000. Amyloid. 7:23–25.
   PubMed Web of Science ®Google Scholar
• Klein CJ, Vrana JA, Theis JD, Dyck PJ, Dyck PJB, Spinner RJ, Mauermann ML, Bergen HR, III, Zeldenrust SR, Dogan A. 2011. Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue. Arch Neurol. 68:195–199.
   PubMedGoogle Scholar
• Klimtchuk ES, Prokaeva T, Frame NM, Abdullahi HA, Spencer B, Dasari S, Cui H, Berk JL, Kurtin PJ, Connors LH, et al. 2018. Unusual duplication mutation in a surface loop of human transthyretin leads to an aggressive drug-resistant amyloid disease. Proc Natl Acad Sci USA. 115:E6428–E6436.
   PubMed Web of Science ®Google Scholar
• Kourelis TV, Dasari SS, Dispenzieri A, Maleszewski JJ, Redfield MM, Fayyaz AU, Grogan M, Ramirez-Alvarado M, Abou Ezzeddine OF, McPhail ED. 2020. A proteomic atlas of cardiac amyloid plaques. CardioOncology. 2:632–643.
   PubMedGoogle Scholar
• Krance SH, Wu C-Y, Zou Y, Mao H, Toufighi S, He X, Pakosh M, Swardfager W. 2019. The complement cascade in Alzheimer's disease: a systematic review and meta-analysis. Mol Psychiatry.
   PubMedGoogle Scholar
• Lavatelli F, Perlman DH, Spencer B, Prokaeva T, McComb ME, Théberge R, Connors LH, Bellotti V, Seldin DC, Merlini G, et al. 2008. Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. Mol Cell Proteomics. 7:1570–1583.
   PubMed Web of Science ®Google Scholar
• Lee K-W, Lee D-H, Son H, Kim Y-S, Park J-Y, Roh G-S, Kim H-J, Kang S-S, Cho G-J, Choi W-S. 2009. Clusterin regulates transthyretin amyloidosis. Biochem Biophys Res Commun. 388:256–260.
   PubMed Web of Science ®Google Scholar
• Lepelletier F-X, Mann DMA, Robinson AC, Pinteaux E, Boutin H. 2017. Early changes in extracellular matrix in Alzheimer's disease. Neuropathol Appl Neurobiol. 43:167–182.
   PubMed Web of Science ®Google Scholar
• Lundgren DH, Hwang S-I, Wu L, Han DK. 2014. Role of spectral counting in quantitative proteomics. Expert Rev Proteomics. 7:39–53.
   Google Scholar
• Mahmood S, Bridoux F, Venner CP, Sachchithanantham S, Gilbertson JA, Rowczenio D, Wagner T, Sayed R, Patel K, Fontana M, et al. 2015. Natural history and outcomes in localised immunoglobulin light-chain amyloidosis: a long-term observational study. Lancet Haematol. 2(6):e241–e250.
   PubMed Web of Science ®Google Scholar
• Mangione PP, Mazza G, Gilbertson JA, Rendell NB, Canetti D, Giorgetti S, Frenguelli L, Curti M, Rezk T, Raimondi S, et al. 2017. Increasing the accuracy of proteomic typing by decellularisation of amyloid tissue biopsies. J Proteomics. 165:113–118.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Garlanda C, Doni A, Bottazzi B. 2008. Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. J Clin Immunol. 28:1–13.
   PubMed Web of Science ®Google Scholar
• Martinez JR, Dhawan A, Farach-Carson MC. 2018. Modular proteoglycan perlecan/HSPG2: mutations, Phenotypes, and Functions. Genes. 9(11):556.
   PubMed Web of Science ®Google Scholar
• Merlini G, Bellotti V. 2003. Molecular mechanisms of amyloidosis. N Engl J Med. 349:583–596.
   PubMed Web of Science ®Google Scholar
• Merlini G, Seldin DC, Gertz MA. 2011. Amyloidosis: Pathogenesis and new therapeutic options. J Clin Oncol. 29:1924–1933.
   PubMed Web of Science ®Google Scholar
• Miller DV, Dogan A, Sethi S. 2010. New-onset proteinuria with massive amorphous glomerular deposits. Am J Kidney Dis. 55:749–754.
   PubMed Web of Science ®Google Scholar
• Müller-Eberhard HJ. 1985. The killer molecule of complement. J Invest Dermatol. 85:47s–52s.
   PubMed Web of Science ®Google Scholar
• Narayan P, Orte A, Clarke RW, Bolognesi B, Hook S, Ganzinger KA, Meehan S, Wilson MR, Dobson CM, Klenerman D. 2011. The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-β(1-40) peptide. Nat Struct Mol Biol. 19:79–83.
   PubMed Web of Science ®Google Scholar
• Nasr SH, Dasari S, Hasadsri L, Theis JD, Vrana JA, Gertz MA, Muppa P, Zimmermann MT, Grogg KL, Dispenzieri A, et al. 2017. Novel type of renal amyloidosis derived from apolipoprotein-CII. J Am Soc Nephrol. 28:439–445.
   PubMed Web of Science ®Google Scholar
• Nasr SH, Dogan A, Larsen CP. 2015. Leukocyte cell-derived chemotaxin 2-associated amyloidosis: a recently recognized disease with distinct clinicopathologic characteristics. Clin J Am Soc Nephrol. 10:2084–2093.
   PubMed Web of Science ®Google Scholar
• Noursadeghi M, Bickerstaff MC, Gallimore JR, Herbert J, Cohen J, Pepys MB. 2000. Role of serum amyloid P component in bacterial infection: Protection of the host or protection of the pathogen. Proc Natl Acad Sci USA. 97:14584–14589.
   PubMed Web of Science ®Google Scholar
• Oskarsson ME, Paulsson JF, Schultz SW, Ingelsson M, Westermark P, Westermark GT. 2015. In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and alzheimer disease. Am J Pathol. 185(3):834–846.
   PubMed Web of Science ®Google Scholar
• Otaka Y, Nakazato Y, Tsutsui T, Tamura J. 2019. Cardiac involvement in heavy and light chain amyloidosis: a case report and literature review. Medicine. 98:e17999.
   PubMed Web of Science ®Google Scholar
• Pepys MB, Booth DR, Hutchinson WL, Gallimore JR, Collins IM, Hohenester E. 1997. Amyloid P component. A Critical Review. Amyloid. 4(4):274–295.
   Web of Science ®Google Scholar
• Pepys MB, Butler PJG. 1987. Serum amyloid P component is the major calcium-dependent specific DNA binding protein of the serum. Biochem Biophys Res Commun. 148(1):308–313.
   PubMed Web of Science ®Google Scholar
• Pepys MB, Dyck RF, Fc de B, Skinner M, Cohen AS. 1979. Binding of serum amyloid P-component (SAP) by amyloid fibrils. Clin Exp Immunol. 38:284–293.
   PubMed Web of Science ®Google Scholar
• Pepys MB, Herbert J, Hutchinson WL, Tennent GA, Lachmann HJ, Gallimore JR, Lovat LB, Bartfai T, Alanine A, Hertel C, et al. 2002. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature. 417:254–259.
   PubMed Web of Science ®Google Scholar
• Pepys MB. 2018. The pentraxins 1975-2018: serendipity, diagnostics and drugs. Front Immunol. 9:2382.
   PubMed Web of Science ®Google Scholar
• Picken MM. 2015. Proteomics and mass spectrometry in the diagnosis of renal amyloidosis. Clin Kidney J. 8(6):665–672.
   PubMed Web of Science ®Google Scholar
• Poulsen ET, Pedersen KW, Marzeda AM, Enghild JJ. 2017. Serum amyloid P Component (SAP) interactome in human plasma containing physiological calcium levels. Biochemistry. 56:896–902.
   PubMed Web of Science ®Google Scholar
• Pozzi A, Yurchenco PD, Iozzo RV. 2017. The nature and biology of basement membranes. Matrix Biol. 57-58:1–11.
   PubMed Web of Science ®Google Scholar
• Puchtler H, Sweat F, Levine M. 1962. On the binding of congo red by amyloid. J Histochem Cytochem. 10(3):355–364.
   Web of Science ®Google Scholar
• R Core Team 2020. R: A language and environment for statistical computing. R 4.0.0. Vienna, Austria: R Foundation for Statistical Computing. https://www.r-project.org/.
   Google Scholar
• Ravindran A, Grogg KL, Domaas DA, Go RS. 2016. Polyclonal localized light chain amyloidosis—a distinct entity? Clin Lymphoma Myeloma Leuk. 16:588–592.
   PubMed Web of Science ®Google Scholar
• Renner B, Tong HH, Laskowski J, Jonscher K, Goetz L, Woolaver R, Hannan J, Li YX, Hourcade D, Pickering MC, et al. 2016. Annexin A2 enhances complement activation by inhibiting factor H. J Immunol. 196:1355–1365.
   PubMed Web of Science ®Google Scholar
• Richards DB, Cookson LM, Barton SV, Liefaard L, Lane T, Hutt DF, Ritter JM, Fontana M, Moon JC, Gillmore JD, et al. 2018. Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis. Sci Transl Med. 10(422):eaan3128.
   PubMed Web of Science ®Google Scholar
• Richards DB, Cookson LM, Berges AC, Barton SV, Lane T, Ritter JM, Fontana M, Moon JC, Pinzani M, Gillmore JD, et al. 2015. Therapeutic clearance of amyloid by antibodies to serum amyloid P component. N Engl J Med. 373:1106–1114.
   PubMed Web of Science ®Google Scholar
• Ricklin D, Hajishengallis G, Yang K, Lambris JD. 2010. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 11:785–797.
   PubMed Web of Science ®Google Scholar
• Rodriguez FJ, Gamez JD, Vrana JA, Theis JD, Giannini C, Scheithauer BW, Parisi JE, Lucchinetti CF, Pendlebury WW, Bergen HR, III, et al. 2008. Immunoglobulin derived depositions in the nervous system: novel mass spectrometry application for protein characterization in formalin-fixed tissues. Lab Invest. 88:1024–1037.
   PubMed Web of Science ®Google Scholar
• Rowczenio D, Dogan A, Theis JD, Vrana JA, Lachmann HJ, Wechalekar AD, Gilbertson JA, Hunt T, Gibbs SDJ, Sattianayagam PT, et al. 2011. Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I. Am J Pathol. 179:1978–1987.
   PubMed Web of Science ®Google Scholar
• Sethi S, Dasari S, Plaisier E, Ronco P, Nasr SH, Brocheriou I, Theis JD, Vrana JA, Zimmermann MT, Quint PS, et al. 2018. Apolipoprotein CII amyloidosis associated with p.Lys41Thr mutation. Kidney Int Rep. 3:1193–1201.
   PubMed Web of Science ®Google Scholar
• Sethi S, Fervenza FC, Miller D, Norby S, Leung N. 2010. Recurrence of amyloidosis in a kidney transplant. Am J Kidney Dis. 56:394–398.
   PubMed Web of Science ®Google Scholar
• Sethi S, Theis JD, Leung N, Dispenzieri A, Nasr SH, Fidler ME, Cornell LD, Gamez JD, Vrana JA, Dogan A. 2010. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis. Clin J Am Soc Nephrol. 5:2180–2187.
   PubMed Web of Science ®Google Scholar
• Sethi S, Theis JD, Quint P, Maierhofer W, Kurtin PJ, Dogan A, Highsmith EW. Jr. 2013. Renal amyloidosis associated with a novel sequence variant of gelsolin. Am J Kidney Dis. 61(1):161–166.
   PubMed Web of Science ®Google Scholar
• Sethi S, Theis JD, Shiller SM, Nast CC, Harrison D, Rennke HG, Vrana JA, Dogan A. 2012. Medullary amyloidosis associated with apolipoprotein A-IV deposition. Kidney Int. 81:201–206.
   PubMed Web of Science ®Google Scholar
• Sethi S, Theis JD, Vrana JA, Fervenza FC, Sethi A, Qian Q, Quint P, Leung N, Dogan A, Nasr SH. 2013. Laser microdissection and proteomic analysis of amyloidosis, cryoglobulinemic GN, fibrillary GN, and immunotactoid glomerulopathy. Clin J Am Soc Nephrol. 8:915–921.
   PubMed Web of Science ®Google Scholar
• Sidiqi MH, McPhail ED, Theis JD, Dasari S, Vrana JA, Drosou ME, Leung N, Hayman S, Rajkumar SV, Warsame R, et al. 2019. Two types of amyloidosis presenting in a single patient: a case series. Blood Cancer J. 9(3):1924.
   Google Scholar
• Sjöberg AP, Trouw LA, Blom AM. 2009. Complement activation and inhibition: a delicate balance. Trends Immunol. 30:83–90.
   PubMed Web of Science ®Google Scholar
• Sridharan M, Highsmith WE, Kurtin PJ, Zimmermann MT, Theis JD, Dasari S, Dingli D. 2018. A patient with hereditary ATTR and a novel AGel p.Ala578Pro amyloidosis. Mayo Clin Proc. 93:1678–1682.
   PubMed Web of Science ®Google Scholar
• Stuhlmann-Laeisz C, Schönland SO, Hegenbart U, Oschlies I, Baumgart J-V, Krüger S, Röcken C. 2019. AL amyloidosis with a localized B cell neoplasia. Virchows Arch. 474:353–363.
   PubMed Web of Science ®Google Scholar
• Sun W, Sun J, Zou L, Shen K, Zhong D, Zhou D, Sun W, Li J. 2015. The successful diagnosis and typing of systemic amyloidosis using a microwave-assisted filter-aided fast sample preparation method and LC/MS/MS analysis. PLoS One. 10:e0127180.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, et al. 2019. STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47:D607–D613.
   PubMed Web of Science ®Google Scholar
• Theis JD, Dasari S, Vrana JA, Kurtin PJ, Dogan A. 2013. Shotgun-proteomics-based clinical testing for diagnosis and classification of amyloidosis. J Mass Spectrom. 48:1067–1077.
   PubMed Web of Science ®Google Scholar
• UniProt Consortium. 2019. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 47:D506–D515.
   PubMed Web of Science ®Google Scholar
• Vrana JA, Gamez JD, Madden BJ, Theis JD, Bergen HR, III, Dogan A. 2009. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood. 114:4957–4959.
   PubMed Web of Science ®Google Scholar
• Vrana JA, Theis JD, Dasari S, Mereuta OM, Dispenzieri A, Zeldenrust SR, Gertz MA, Kurtin PJ, Grogg KL, Dogan A. 2014. Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics. Haematologica. 99:1239–1247.
   PubMed Web of Science ®Google Scholar
• Wickham H, Averick M, Bryan J, Chang W, McGowan L, François R, Grolemund G, Hayes A, Henry L, Hester J, et al. 2019. Welcome to the Tidyverse. JOSS. 4(43):1686.
   Google Scholar
• Wickham H. 2016. ggplot2: elegant graphics for data analysis. Cham: Springer. p. 140. p. (Use R!). https://ggplot2.tidyverse.org/.
   Google Scholar
• Wilson MR, Yerbury JJ, Poon S. 2008. Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity. Mol Biosyst. 4:42–52.
   PubMed Web of Science ®Google Scholar
• Winter M, Tholey A, Kristen A, Röcken C. 2017. MALDI mass spectrometry imaging: a novel tool for the identification and classification of amyloidosis. Proteomics. 17(22):1700236.
   Web of Science ®Google Scholar
• Winter M, Tholey A, Krüger S, Schmidt H, Röcken C. 2015. MALDI-mass spectrometry imaging identifies vitronectin as a common constituent of amyloid deposits. J Histochem Cytochem. 63:772–779.
   PubMed Web of Science ®Google Scholar
• Wisniewski T, Drummond E. 2020. APOE-amyloid interaction: therapeutic targets. Neurobiol Dis. 138:104784.
   PubMed Web of Science ®Google Scholar
• Yang X, Okamura DM, Lu X, Chen Y, Moorhead J, Varghese Z, Ruan XZ. 2017. CD36 in chronic kidney disease: novel insights and therapeutic opportunities. Nat Rev Nephrol. 13:769–781.
   PubMed Web of Science ®Google Scholar
• Yerbury JJ, Poon S, Meehan S, Thompson B, Kumita JR, Dobson CM, Wilson MR. 2007. The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. Faseb J. 21:2312–2322.
   PubMed Web of Science ®Google Scholar